miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer

FEBS Lett. 2015 Jan 30;589(3):407-13. doi: 10.1016/j.febslet.2014.12.027. Epub 2014 Dec 29.

Abstract

MicroRNAs (miRNAs) play a prominent role in gastric cancer (GC) initiation and progression. In this study, we found that miR-374a expression was up-regulated in human GC cell lines and tissues. Inhibition of miR-374a suppressed GC cell proliferation, migration and invasion in vitro and slowed tumor growth in vivo. SRC kinase signaling inhibitor 1 (SRCIN1) was identified as a direct target of miR-374a. Silencing of SRCIN1 significantly enhanced cell proliferation, migration and invasion, whereas SRCIN1 reintroduction partially abrogated the oncogenic effects of miR-374a. Taken together, these findings suggest that miR-374a functions as a candidate oncogene in GC by directly targeting SRCIN1. miR-374a may therefore be useful as a promising therapeutic target for malignant GC.

Keywords: Gastric cancer; SRC kinase signaling inhibitor 1; miR-374a.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport / biosynthesis*
  • Adaptor Proteins, Vesicular Transport / genetics
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs / genetics*
  • Molecular Targeted Therapy
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology

Substances

  • Adaptor Proteins, Vesicular Transport
  • MIRN374 microRNA 374, human
  • MicroRNAs
  • SRCIN1 protein, human